Full-Time

QA Manager

DHR Review

Confirmed live in the last 24 hours

Penumbra Inc

Penumbra Inc

1,001-5,000 employees

Develops medical devices for vascular conditions

Biotechnology
Healthcare

Compensation Overview

$105k - $165kAnnually

Mid, Senior

Alameda, CA, USA

This position is onsite in Alameda, CA.

Category
QA & Testing
Quality Assurance
Required Skills
Data Analysis
Requirements
  • A Bachelor's degree with 4+ years of experience in Quality Assurance, Quality Control, biotechnology, document control, or a related field, or equivalent combination of education and demonstrated experience
  • Proficiency with Microsoft Office (e.g., Word, Excel, PowerPoint, etc.)
  • Knowledge of global medical device regulations and standards including FDA and ISO 13485
  • Demonstrated experience in managing and leading a team
  • Strong analytical, problem solving, decision-making, and leadership skills are required
  • High degree of accuracy and attention to detail
  • Strong oral, written and interpersonal communication skills
Responsibilities
  • Select, manage, train, and develop staff. Establish objectives and assignments and provide ongoing feedback through performance reviews and development plans.
  • Lead, manage, and motivate a team performing DHR review activities while providing guidance, training, and support to ensure high performance and continuous development.
  • Oversee the DHR review process to ensure compliance with applicable regulations and standards and internal quality policies.
  • Communicate effectively both within area of responsibility and cross-functionally to ensure daily priorities are in alignment.
  • Develop and maintain quality metrics for area of responsibility.
  • Formulate and carry out company directives based on knowledge of the company’s Quality Management System (QMS).
  • Evaluate procedures for processing improvements, recommend changes to procedures and implement changes, as necessary.
  • Participate in internal and external audits, including the retrieval of quality records and any other documentation requested, and represent DHR review processes.
  • Provide additional analysis of situations reviewing various factors to solve problems and proactively seek and implement improvements.

Penumbra Inc. specializes in creating medical devices aimed at treating neurovascular and peripheral vascular conditions. Their products, such as the Penumbra System and the Indigo System, are designed to assist healthcare professionals in addressing issues like stroke and other vascular diseases. These devices work by providing advanced tools for interventions in neurology and vascular surgery, allowing for effective treatment options. Unlike many competitors, Penumbra focuses on a specific range of conditions and invests heavily in research and development to continuously enhance their offerings. The company's goal is to deliver high-quality medical devices that meet the needs of healthcare providers and improve patient outcomes.

Company Stage

IPO

Total Funding

$116.7K

Headquarters

Alameda, California

Founded

2004

Growth & Insights
Headcount

6 month growth

4%

1 year growth

11%

2 year growth

20%
Simplify Jobs

Simplify's Take

What believers are saying

  • Penumbra's recent product launches, such as the BMX81 and BMX96 in Europe, demonstrate their commitment to expanding and improving their product portfolio.
  • Significant investments from firms like Jennison Associates LLC and Algert Global LLC indicate strong financial backing and confidence in Penumbra's growth potential.
  • The company's participation in high-profile conferences like the Truist Securities MedTech Conference and the William Blair Growth Stock Conference highlights its industry recognition and thought leadership.

What critics are saying

  • The highly competitive medical device market requires Penumbra to continuously innovate to maintain its market position.
  • Regulatory challenges and the need for CE Marks and FDA approvals can delay product launches and impact revenue.

What makes Penumbra Inc unique

  • Penumbra's focus on both neurovascular and peripheral vascular conditions sets it apart from competitors who may specialize in only one area.
  • Their continuous investment in R&D ensures that they remain at the forefront of medical device innovation, particularly with recent launches like the Lightning Flash 2.0 CAVT technology.
  • Penumbra's global reach, serving healthcare providers in over 100 countries, provides a broad market presence that many competitors lack.

Help us improve and share your feedback! Did you find this helpful?